Genuity Science is a wholly-owned subsidiary of US biotechnology company, HiberCell. Genuity Science is using world-leading genomics and machine learning to map the causal biology of disease and accelerate the development of better medicine. Our unique hybrid platform enables us and our partners to go from data to insights to impact with unrivaled power and efficiency, generating, validating and applying insights on virtually any disease to create novel drugs, diagnostics and tools for clinical care. Our capabilities span deeply phenotyped population genomics cohorts, CAP-accredited sequencing and comprehensive omics, world-renowned bioinformatics, and pioneering, validated and peer-reviewed AI/ML. Through our offices in Boston, Dublin and Reykjavik we put this platform to work for our global biopharma and life sciences partners and the patients they serve. To learn more, visit us at www.genuitysci.com.
Location: United States, Massachusetts, Boston
Employees: 51-200
Phone: +1 617-250-3500
Founded date: 2013
Investors 1
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 28.06.2021 | Accelerating Lupus Drug Discovery & Development: Firesid... | Register for this webinar hear an examination of why researching lupus is so complex and the fundame... | prweb.com/... |
| 01.04.2021 | Genomic Validation of Novel Therapeutic Targets in Neurodege... | While several monogenetic variants contribute to familial heritability of Alzheimer’s and Parkinson’... | prweb.com/... |
| 02.02.2021 | Genomic Advances in Heart Failure, Upcoming Webinar Hosted b... | The speakers will discuss what is currently known about genomic drivers of heart failure and opportu... | prweb.com/... |
| 23.06.2020 | Meet the latest genomic data company — aka WuXi NextCO... | Just five years after WuXi engineered a deal to merge its genome center with NextCODE Health, th... | endpts.com... |